Bendanillo, Silvestre .
HRN: 26-72-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2025
CEFTRIAXONE 1G (VIAL)
02/18/2025
02/25/2025
IV
2g
OD
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes